ImmuCell Corporation (ICCC)

NASDAQ: ICCC · Real-Time Price · USD

6.44

+0.09 (1.42%)

At close: Apr 2, 2026, 4:00 PM EDT

6.57

+0.13 (2.02%)

After-hours: Apr 2, 2026, 4:45 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Scours			17.29M	18.41M	18.93M	-	-
Scours Growth			-6.07%	-2.75%	-	-	-
Mastitis			177.74K	154.56K	143.28K	-	-
Mastitis Growth			15.00%	7.87%	-	-	-
Other			-	1.46K	166.60K	-	-
Other Growth			-	-99.13%	-	-	-
Biotechnology			-	-	-	15.34M	13.72M
Biotechnology Growth			-	-	-	11.80%	24.91%
Total			17.47M	18.57M	19.24M	15.34M	13.72M
Total Growth			-5.90%	-3.51%	25.43%	11.80%	24.91%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States			15.95M	17.02M	16.62M	13.64M	12.19M
United States Growth			-6.29%	2.41%	21.81%	11.92%	27.53%
Other			1.52M	1.55M	2.62M	1.70M	1.53M
Other Growth			-1.61%	-41.01%	54.50%	10.82%	7.33%
Total			17.47M	18.57M	19.24M	15.34M	13.72M
Total Growth			-5.90%	-3.51%	25.43%	11.80%	24.91%

Source: S&P Global Market Intelligence.